BPMC Insider Trading

Insider Ownership Percentage: 4.21%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $31,397,044.73

Blueprint Medicines Insider Trading History Chart

This chart shows the insider buying and selling history at Blueprint Medicines by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Blueprint Medicines Share Price & Price History

Current Price: $94.81
Price Change: Price Increase of +0.21 (0.22%)
As of 11/20/2024 01:00 AM ET

This chart shows the closing price history over time for BPMC up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Blueprint Medicines Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
10/3/2024Fouad NamouniInsiderSell3,633$89.32$324,499.5669,070View SEC Filing Icon  
8/5/2024Philina LeeInsiderSell41,913$93.19$3,905,872.4734,729View SEC Filing Icon  
7/5/2024Debra Durso-BumpusInsiderSell3,850$111.20$428,120.0043,763View SEC Filing Icon  
7/3/2024Debra Durso-BumpusInsiderSell8,817$111.29$981,243.9343,763View SEC Filing Icon  
6/28/2024Debra Durso-BumpusInsiderSell333$111.15$37,012.9543,763View SEC Filing Icon  
6/21/2024Debra Durso-BumpusInsiderSell74,034$104.19$7,713,602.4643,763View SEC Filing Icon  
6/5/2024Percy H. CarterInsiderSell4,000$105.13$420,520.0041,895View SEC Filing Icon  
6/3/2024L. Becker HewesInsiderSell4,922$106.43$523,848.4631,938View SEC Filing Icon  
5/31/2024L. Becker HewesInsiderSell34,108$105.91$3,612,378.2836,860View SEC Filing Icon  
5/2/2024Ariel HurleyInsiderSell1,834$103.88$190,515.9214,913View SEC Filing Icon  
5/2/2024Michael LandsittelCFOSell10,000$105.00$1,050,000.0047,286View SEC Filing Icon  
3/28/2024Michael LandsittelCFOSell5,000$95.00$475,000.0047,286View SEC Filing Icon  
3/20/2024Jeffrey W. AlbersDirectorSell25,073$87.28$2,188,371.44176,050View SEC Filing Icon  
3/15/2024Michael LandsittelCFOSell13,734$87.78$1,205,570.5247,286View SEC Filing Icon  
3/7/2024Christina RossiCOOSell6,070$90.69$550,488.3064,306View SEC Filing Icon  
3/7/2024Jeffrey W. AlbersDirectorSell11,033$90.69$1,000,582.77165,017View SEC Filing Icon  
3/7/2024Kate HavilandCEOSell12,464$90.69$1,130,360.16153,177View SEC Filing Icon  
3/7/2024L. Becker HewesInsiderSell3,097$90.69$280,866.9346,281View SEC Filing Icon  
3/7/2024Michael LandsittelCFOSell5,003$90.69$453,722.0756,020View SEC Filing Icon  
3/7/2024Tracey L. MccainEVPSell5,194$90.69$471,043.8660,498View SEC Filing Icon  
3/4/2024Christopher K. MurrayInsiderSell621$93.65$58,156.6536,374View SEC Filing Icon  
2/28/2024Christopher K. MurrayInsiderSell5,000$100.00$500,000.0024,495View SEC Filing Icon  
1/25/2024Jeffrey W. AlbersDirectorSell25,000$81.91$2,047,750.00176,050View SEC Filing Icon  
12/22/2023Ariel HurleyInsiderSell714$90.00$64,260.0014,324View SEC Filing Icon  
12/7/2023Christopher K. MurrayInsiderSell5,000$75.00$375,000.0024,495View SEC Filing Icon  
12/4/2023Christopher K. MurrayInsiderSell600$71.43$42,858.0024,495View SEC Filing Icon  
11/30/2023Jeffrey W. AlbersDirectorSell5,000$70.55$352,750.00176,050View SEC Filing Icon  
11/24/2023Jeffrey W. AlbersDirectorSell15,000$67.51$1,012,650.00176,050View SEC Filing Icon  
11/3/2023Jeffrey W. AlbersDirectorSell1,485$60.13$89,293.05176,050View SEC Filing Icon  
11/1/2023Jeffrey W. AlbersDirectorSell3,881$60.02$232,937.62176,050View SEC Filing Icon  
10/26/2023Christopher K. MurrayInsiderSell600$56.40$33,840.0025,095View SEC Filing Icon  
10/4/2023Fouad NamouniInsiderSell3,769$48.06$181,138.1462,080View SEC Filing Icon  
9/28/2023Jeffrey W. AlbersDirectorSell6,898$50.17$346,072.66176,050View SEC Filing Icon  
8/25/2023Jeffrey W. AlbersDirectorSell10,000$50.16$501,600.00176,050View SEC Filing Icon  
6/5/2023Percy H. CarterInsiderSell2,307$52.06$120,102.4238,117View SEC Filing Icon  
3/6/2023Christina RossiCOOSell3,059$45.67$139,704.5355,376View SEC Filing Icon  
3/6/2023Christopher K. MurrayInsiderSell1,875$45.68$85,650.0025,695View SEC Filing Icon  
3/6/2023Jeffrey W. AlbersDirectorSell9,793$45.67$447,246.31173,450View SEC Filing Icon  
3/6/2023Kate HavilandCEOSell6,640$45.69$303,381.60125,641View SEC Filing Icon  
3/6/2023Michael LandsittelCFOSell3,007$45.68$137,359.7648,523View SEC Filing Icon  
3/6/2023Tracey L. MccainEVPSell3,322$45.68$151,748.9652,666View SEC Filing Icon  
12/5/2022Jeffrey W. AlbersDirectorSell20,000$50.09$1,001,800.00183,243View SEC Filing Icon  
11/3/2022Christina RossiCOOSell533$45.24$24,112.9243,435View SEC Filing Icon  
11/3/2022Kate HavilandCEOBuy1,100$43.98$48,378.0092,281View SEC Filing Icon  
10/4/2022Fouad NamouniInsiderSell3,477$67.30$234,002.1052,797View SEC Filing Icon  
8/24/2022Debra Durso-BumpusInsiderSell5,000$75.11$375,550.0040,836View SEC Filing Icon  
8/22/2022Jeffrey W. AlbersDirectorSell8,410$70.54$593,241.40183,243View SEC Filing Icon  
8/19/2022Jeffrey W. AlbersDirectorSell1,590$70.02$111,331.80183,243View SEC Filing Icon  
8/16/2022Jeffrey W. AlbersDirectorSell20,000$68.41$1,368,200.00183,243View SEC Filing Icon  
8/8/2022Jeffrey W. AlbersDirectorSell10,000$70.07$700,700.00183,243View SEC Filing Icon  
8/4/2022Christopher K. MurraySVPSell2,500$60.44$151,100.0021,320View SEC Filing Icon  
6/6/2022Percy H. CarterInsiderSell1,908$59.76$114,022.0828,685View SEC Filing Icon  
4/6/2022Jeffrey W. AlbersCEOSell5,000$70.11$350,550.00183,243View SEC Filing Icon  
3/17/2022George DemetriDirectorSell10$58.56$585.605,812View SEC Filing Icon  
3/16/2022L. Becker HewesInsiderSell2,219$60.00$133,140.00View SEC Filing Icon  
3/10/2022Ariel HurleyInsiderSell2,339$57.15$133,673.85View SEC Filing Icon  
3/7/2022Ariel HurleyInsiderSell256$56.19$14,384.64View SEC Filing Icon  
3/3/2022Ariel HurleyInsiderSell761$60.27$45,865.47View SEC Filing Icon  
3/3/2022Mark Alan GoldbergDirectorBuy5,000$59.98$299,900.00View SEC Filing Icon  
12/15/2021L. Becker HewesInsiderSell729$100.00$72,900.00View SEC Filing Icon  
12/13/2021Kate HavilandCOOSell1,000$98.30$98,300.00View SEC Filing Icon  
12/7/2021Tracey L. MccainEVPSell5,000$97.30$486,500.00View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Blueprint Medicines (NASDAQ:BPMC)

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at BPMC by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Blueprint Medicines Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
11/18/2024Teachers Retirement System of The State of Kentucky16,520$1.53M0.0%+23.7%0.026%Search for SEC Filing on Google Icon
11/16/2024Geode Capital Management LLC1,480,187$136.94M0.0%+1.4%2.330%Search for SEC Filing on Google Icon
11/15/2024Barclays PLC171,196$15.84M0.0%-27.9%0.269%Search for SEC Filing on Google Icon
11/15/2024Nomura Asset Management Co. Ltd.22,557$2.09M0.0%+13.8%0.036%Search for SEC Filing on Google Icon
11/15/2024Y Intercept Hong Kong Ltd2,662$0.25M0.0%+27.6%0.004%Search for SEC Filing on Google Icon
11/15/2024XTX Topco Ltd2,200$0.20M0.0%-60.0%0.003%Search for SEC Filing on Google Icon
11/15/2024Zimmer Partners LP21,100$1.95M0.0%N/A0.033%Search for SEC Filing on Google Icon
11/15/2024Castleark Management LLC33,990$3.14M0.1%-13.8%0.054%Search for SEC Filing on Google Icon
11/15/2024Wellington Management Group LLP3,964,610$366.73M0.1%+22.5%6.241%Search for SEC Filing on Google Icon
11/15/2024State Street Corp2,765,702$255.83M0.0%+16.2%4.353%Search for SEC Filing on Google Icon
11/15/2024Quarry LP350$32K0.0%N/A0.001%Search for SEC Filing on Google Icon
11/15/2024Readystate Asset Management LP56,500$5.23M0.1%N/A0.089%Search for SEC Filing on Google Icon
11/15/2024Ikarian Capital LLC85,000$7.86M1.1%N/A0.134%Search for SEC Filing on Google Icon
11/15/2024Jacobs Levy Equity Management Inc.496,087$45.89M0.2%+161.1%0.781%Search for SEC Filing on Google Icon
11/15/2024Holocene Advisors LP16,914$1.57M0.0%-98.2%0.027%Search for SEC Filing on Google Icon
11/15/2024Cinctive Capital Management LP74,341$6.88M0.4%+10.1%0.117%Search for SEC Filing on Google Icon
11/15/2024Erste Asset Management GmbH25,100$2.32M0.0%N/A0.040%Search for SEC Filing on Google Icon
11/14/2024Bellevue Group AG3,200$0.30M0.0%-37.3%0.005%Search for SEC Filing on Google Icon
11/14/2024Edgestream Partners L.P.56,123$5.19M0.2%+443.7%0.088%Search for SEC Filing on Google Icon
11/14/2024Fred Alger Management LLC33,110$3.06M0.0%-31.9%0.052%Search for SEC Filing on Google Icon
11/14/2024Eventide Asset Management LLC348,704$32.26M0.6%+50.5%0.549%Search for SEC Filing on Google Icon
11/14/2024Verition Fund Management LLC9,759$0.90M0.0%+77.5%0.015%Search for SEC Filing on Google Icon
11/14/2024Captrust Financial Advisors17,904$1.66M0.0%+3.4%0.028%Search for SEC Filing on Google Icon
11/14/2024Martingale Asset Management L P15,603$1.44M0.0%+7.6%0.025%Search for SEC Filing on Google Icon
11/14/2024Alkeon Capital Management LLC718,928$66.50M0.1%-19.6%1.132%Search for SEC Filing on Google Icon
11/14/2024UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC227,911$21.08M0.0%-24.5%0.359%Search for SEC Filing on Google Icon
11/14/2024Ally Bridge Group NY LLC106,080$9.81M5.3%+40.2%0.167%Search for SEC Filing on Google Icon
11/14/2024Zurcher Kantonalbank Zurich Cantonalbank 13,613$1.26M0.0%-1.3%0.021%Search for SEC Filing on Google Icon
11/14/2024Blueshift Asset Management LLC2,998$0.28M0.1%N/A0.005%Search for SEC Filing on Google Icon
11/13/2024Quantbot Technologies LP1,164$0.11M0.0%N/A0.002%Search for SEC Filing on Google Icon
11/13/2024FMR LLC4,516,771$417.80M0.0%-6.6%7.110%Search for SEC Filing on Google Icon
11/13/2024The Manufacturers Life Insurance Company 149,996$13.88M0.0%-11.1%0.236%Search for SEC Filing on Google Icon
11/13/2024Bank of Montreal Can68,562$6.35M0.0%-0.7%0.108%Search for SEC Filing on Google Icon
11/13/2024Fisher Asset Management LLC335,350$31.02M0.0%-0.2%0.528%Search for SEC Filing on Google Icon
11/12/2024Pitcairn Co.10,315$0.95M0.1%+127.6%0.016%Search for SEC Filing on Google Icon
11/12/2024Algert Global LLC92,236$8.53M0.2%+40.7%0.145%Search for SEC Filing on Google Icon
11/12/2024Citigroup Inc.143,441$13.27M0.0%+19.3%0.226%Search for SEC Filing on Google Icon
11/12/2024Valence8 US LP2,618$0.24M0.1%N/A0.004%Search for SEC Filing on Google Icon
11/12/2024Eagle Asset Management Inc.154,652$15.59M0.1%-18.1%0.243%Search for SEC Filing on Google Icon
11/12/2024Charles Schwab Investment Management Inc.597,232$55.24M0.0%+9.3%0.940%Search for SEC Filing on Google Icon
11/12/2024Massachusetts Financial Services Co. MA252,236$23.33M0.0%+48.8%0.397%Search for SEC Filing on Google Icon
11/9/2024Intech Investment Management LLC18,511$1.71M0.0%N/A0.029%Search for SEC Filing on Google Icon
11/8/2024BNP PARIBAS ASSET MANAGEMENT Holding S.A.69,887$6.47M0.0%N/A0.110%Search for SEC Filing on Google Icon
11/8/2024Advisors Asset Management Inc.5,054$0.47M0.0%+17.6%0.008%Search for SEC Filing on Google Icon
11/8/2024Connor Clark & Lunn Investment Management Ltd.5,132$0.48M0.0%N/A0.008%Search for SEC Filing on Google Icon
11/8/2024Segall Bryant & Hamill LLC141,622$13.10M0.2%+11.6%0.223%Search for SEC Filing on Google Icon
11/7/2024Pathstone Holdings LLC20,131$1.86M0.0%-9.4%0.032%Search for SEC Filing on Google Icon
11/7/2024First Turn Management LLC178,929$16.55M2.6%-3.2%0.282%Search for SEC Filing on Google Icon
11/7/2024Quest Partners LLC1,552$0.14M0.0%-7.1%0.002%Search for SEC Filing on Google Icon
11/7/2024Swiss National Bank116,200$10.75M0.0%+1.6%0.183%Search for SEC Filing on Google Icon
11/7/2024S&CO Inc.10,000$0.93M0.1%+49.3%0.016%Search for SEC Filing on Google Icon
11/6/2024Mutual of America Capital Management LLC32,144$2.97M0.0%-0.9%0.051%Search for SEC Filing on Google Icon
11/5/2024Victory Capital Management Inc.190,361$17.61M0.0%-28.2%0.300%Search for SEC Filing on Google Icon
11/5/2024Prime Capital Investment Advisors LLC3,464$0.32M0.0%-65.2%0.005%Search for SEC Filing on Google Icon
11/5/2024Entropy Technologies LP10,800$1M0.1%N/A0.017%Search for SEC Filing on Google Icon
11/4/2024Los Angeles Capital Management LLC11,179$1.03M0.0%-22.6%0.018%Search for SEC Filing on Google Icon
11/4/2024State of New Jersey Common Pension Fund D22,846$2.11M0.0%-5.6%0.036%Search for SEC Filing on Google Icon
11/2/2024Covestor Ltd598$55K0.0%+206.7%0.001%Search for SEC Filing on Google Icon
10/31/2024Principal Financial Group Inc.11,038$1.02M0.0%-81.0%0.018%Search for SEC Filing on Google Icon
10/31/2024M&G PLC97,861$9.10M0.0%N/A0.156%Search for SEC Filing on Google Icon
10/29/2024Emerald Advisers LLC375,866$34.77M1.4%+10.2%0.600%Search for SEC Filing on Google Icon
10/29/2024Van ECK Associates Corp753$64K0.0%-32.5%0.001%Search for SEC Filing on Google Icon
10/29/2024Emerald Mutual Fund Advisers Trust288,540$26.69M1.4%+3.7%0.461%Search for SEC Filing on Google Icon
10/28/2024Oak Ridge Investments LLC15,135$1.40M0.1%-3.9%0.024%Search for SEC Filing on Google Icon
10/28/2024US Bancorp DE11,971$1.11M0.0%+147.6%0.019%Search for SEC Filing on Google Icon
10/25/2024China Universal Asset Management Co. Ltd.12,183$1.13M0.1%+65.6%0.019%Search for SEC Filing on Google Icon
10/25/2024Pallas Capital Advisors LLC5,657$0.52M0.0%+3.2%0.009%Search for SEC Filing on Google Icon
10/24/2024Nisa Investment Advisors LLC1,893$0.18M0.0%-7.3%0.003%Search for SEC Filing on Google Icon
10/23/2024Mirae Asset Global Investments Co. Ltd.2,291$0.21M0.0%+22.6%0.004%Search for SEC Filing on Google Icon
10/23/2024Mraz Amerine & Associates Inc.5,781$0.54M0.1%-2.8%0.009%Search for SEC Filing on Google Icon
10/23/2024Values First Advisors Inc.1,315$0.12M0.1%N/A0.002%Search for SEC Filing on Google Icon
10/23/2024Assenagon Asset Management S.A.100,633$9.31M0.0%-39.1%0.161%Search for SEC Filing on Google Icon
10/19/2024Allspring Global Investments Holdings LLC3,206$0.30M0.0%+40.7%0.005%Search for SEC Filing on Google Icon
10/16/2024Teamwork Financial Advisors LLC2,700$0.25M0.0%N/A0.004%Search for SEC Filing on Google Icon
10/15/2024NBC Securities Inc.2,725$0.25M0.0%+748.9%0.004%Search for SEC Filing on Google Icon
10/11/2024Creative Planning13,194$1.22M0.0%+6.8%0.021%Search for SEC Filing on Google Icon
10/10/2024Essex Investment Management Co. LLC35,461$3.28M0.6%N/A0.057%Search for SEC Filing on Google Icon
10/10/2024Exchange Traded Concepts LLC2,031$0.19M0.0%-19.9%0.003%Search for SEC Filing on Google Icon
10/9/2024Clarus Wealth Advisors2,590$0.23M0.1%+8.6%0.004%Search for SEC Filing on Google Icon
10/8/2024CWM LLC1,870$0.17M0.0%+69.2%0.003%Search for SEC Filing on Google Icon
10/7/2024Diversified Trust Co15,676$1.45M0.0%-1.5%0.025%Search for SEC Filing on Google Icon
10/3/2024SG Americas Securities LLC2,521$0.23M0.0%-88.4%0.004%Search for SEC Filing on Google Icon
8/27/2024Clearbridge Investments LLC220,980$23.82M0.0%N/A0.353%Search for SEC Filing on Google Icon
8/27/2024Dana Investment Advisors Inc.14,744$1.59M0.1%+8.2%0.024%Search for SEC Filing on Google Icon
8/20/2024Novo Holdings A S175,000$18.86M0.9%-51.2%0.279%Search for SEC Filing on Google Icon
8/16/2024Creative Planning12,351$1.33M0.0%+27.1%0.020%Search for SEC Filing on Google Icon
8/16/2024Algert Global LLC65,540$7.06M0.2%+81.0%0.105%Search for SEC Filing on Google Icon
8/16/2024Driehaus Capital Management LLC358,255$38.61M0.4%+101.0%0.572%Search for SEC Filing on Google Icon
8/15/2024Susquehanna Portfolio Strategies LLC40,277$4.34M0.2%-58.8%0.064%Search for SEC Filing on Google Icon
8/15/2024Mackenzie Financial Corp4,885$0.53M0.0%+5.2%0.008%Search for SEC Filing on Google Icon
8/15/2024The Manufacturers Life Insurance Company168,759$18.19M0.0%-8.4%0.270%Search for SEC Filing on Google Icon
8/15/2024Millennium Management LLC627,626$67.65M0.0%+540.0%1.002%Search for SEC Filing on Google Icon
8/15/2024AQR Capital Management LLC78,103$8.42M0.0%+30.2%0.125%Search for SEC Filing on Google Icon
8/15/2024Alpha DNA Investment Management LLC3,879$0.42M0.2%N/A0.006%Search for SEC Filing on Google Icon
8/15/2024Point72 Europe London LLP13,569$1.46M0.1%N/A0.022%Search for SEC Filing on Google Icon
8/15/2024Point72 Hong Kong Ltd3,339$0.36M0.0%N/A0.005%Search for SEC Filing on Google Icon
8/14/2024Fred Alger Management LLC48,588$5.24M0.0%+187.3%0.078%Search for SEC Filing on Google Icon
8/14/2024Point72 Asset Management L.P.501,581$54.06M0.1%+79.3%0.792%Search for SEC Filing on Google Icon
8/14/2024Marshall Wace LLP351,756$37.91M0.1%+52.7%0.562%Search for SEC Filing on Google Icon
8/14/2024Xponance Inc.4,174$0.45M0.0%+8.2%0.007%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Blueprint Medicines logo
Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibitor for the treatment of indolent SM, and other mast cell disorders. It is also developing GAVRETO for the treatment of RET fusion-positive non-small cell lung cancer, altered thyroid carcinoma, and medullary thyroid carcinoma; BLU-945 for the treatment of epidermal growth factor receptor driven non-small-cell lung carcinoma (NSCLC); and BLU-451 to treat NSCLC in patients with epidermal growth factor receptor gene (EGFR) exon 20 insertion mutations. In addition, the company is developing BLU-782, for the treatment of fibrodysplasia ossificans progressive; BLU- 222 to treat patients with cyclin E aberrant cancers; and BLU-852 for the treatment of advanced cancers. It has collaboration and license agreements with Clementia Pharmaceuticals, Inc.; Proteovant Therapeutics; CStone Pharmaceuticals; Genentech, Inc.; Hoffmann-La Roche Inc.; and Zai Lab (Shanghai) Co., Ltd. The company was formerly known as Hoyle Pharmaceuticals, Inc. and changed its name to Blueprint Medicines Corporation in June 2011. Blueprint Medicines Corporation was incorporated in 2008 and is headquartered in Cambridge, Massachusetts.
Read More on Blueprint Medicines

Today's Range

Now: $94.81
Low: $92.66
High: $95.02

50 Day Range

MA: $90.00
Low: $82.47
High: $101.39

52 Week Range

Now: $94.81
Low: $64.79
High: $121.90

Volume

566,224 shs

Average Volume

692,467 shs

Market Capitalization

$6.02 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.59

Who are the company insiders with the largest holdings of Blueprint Medicines?

Blueprint Medicines' top insider investors include:
  1. Jeffrey W Albers (Director)
  2. Kate Haviland (CEO)
  3. Fouad Namouni (Insider)
  4. Christina Rossi (COO)
  5. Tracey L Mccain (EVP)
  6. Michael Landsittel (CFO)
  7. L Becker Hewes (Insider)
  8. Debra Durso-Bumpus (Insider)
  9. Percy H Carter (Insider)
  10. Christopher K Murray (Insider)
  11. Philina Lee (Insider)
  12. Ariel Hurley (Insider)
Learn More about top insider investors at Blueprint Medicines.

Who are the major institutional investors of Blueprint Medicines?

Blueprint Medicines' top institutional investors include:
  1. FMR LLC — 7.11%
  2. Wellington Management Group LLP — 6.24%
  3. State Street Corp — 4.35%
  4. Geode Capital Management LLC — 2.33%
  5. Alkeon Capital Management LLC — 1.13%
  6. Charles Schwab Investment Management Inc. — 0.94%
Learn More about top institutional investors of Blueprint Medicines stock.

Which major investors are selling Blueprint Medicines stock?

In the previous quarter, BPMC stock was sold by these institutional investors:
  1. Holocene Advisors LP
  2. FMR LLC
  3. Alkeon Capital Management LLC
  4. Victory Capital Management Inc.
  5. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
  6. Barclays PLC
  7. Assenagon Asset Management S.A.
  8. Principal Financial Group Inc.
Within the last year, company insiders that have sold Blueprint Medicines company stock include:
  1. Jeffrey W Albers (Director)
  2. Kate Haviland (CEO)
  3. Fouad Namouni (Insider)
  4. Christina Rossi (COO)
  5. Tracey L Mccain (EVP)
  6. Michael Landsittel (CFO)
  7. L Becker Hewes (Insider)
  8. Debra Durso-Bumpus (Insider)
  9. Percy H Carter (Insider)
  10. Christopher K Murray (Insider)
  11. Philina Lee (Insider)
  12. Ariel Hurley (Insider)
Learn More investors selling Blueprint Medicines stock.

Which major investors are buying Blueprint Medicines stock?

During the last quarter, BPMC stock was bought by institutional investors including:
  1. Wellington Management Group LLP
  2. State Street Corp
  3. Jacobs Levy Equity Management Inc.
  4. Eventide Asset Management LLC
  5. M&G PLC
  6. Ikarian Capital LLC
  7. Massachusetts Financial Services Co. MA
  8. BNP PARIBAS ASSET MANAGEMENT Holding S.A.